SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide) Dear Healthcare Professional Letter, December 2020
A Dear Healthcare Professional Letter was issued for SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide) in December 2020.
Please view the full Prescribing Information, including BOXED WARNING, for SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide).
For product-related questions, please call our contact center at 1-800-Janssen (1-800-526-7736), or email your Medical Information Request and a response will be provided promptly.